Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (91-100 of 420) with videos related to

Pageof 42
Sort By:
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacinA L Barry, P C Fuchs
Journal of Chemotherapy (Florence, Italy)|February 1, 1997
Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacinA L Barry, P C Fuchs
Journal of Clinical Microbiology|October 1, 1996
Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniaeA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|February 1, 1990
In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinoloneR N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephemR N Jones, A L Barry
Antimicrobial Agents and Chemotherapy|March 1, 1976
Inhibition of bacterial growth by the nitrofurantoin solvent dimethylformamideA L Barry, R A Lasner
The American Journal of Medicine|March 22, 1993
Selection of a fluoroquinolone-class disk for susceptibility testsA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|January 1, 1995
In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensA L Barry, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro interaction between the penem FCE 22101 and ceftazidimeA L Barry, R N Jones
Journal of Clinical Microbiology|December 1, 1989
Temafloxacin disk potency and tentative interpretive criteria for susceptibility testsA L Barry, R N Jones
Pageof 42

Showing results (91-100 of 420) with videos related to

Sort By:
Pageof 42
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacinA L Barry, P C Fuchs
Journal of Chemotherapy (Florence, Italy)|February 1, 1997
Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacinA L Barry, P C Fuchs
Journal of Clinical Microbiology|October 1, 1996
Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniaeA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|February 1, 1990
In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinoloneR N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephemR N Jones, A L Barry
Antimicrobial Agents and Chemotherapy|March 1, 1976
Inhibition of bacterial growth by the nitrofurantoin solvent dimethylformamideA L Barry, R A Lasner
The American Journal of Medicine|March 22, 1993
Selection of a fluoroquinolone-class disk for susceptibility testsA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|January 1, 1995
In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensA L Barry, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro interaction between the penem FCE 22101 and ceftazidimeA L Barry, R N Jones
Journal of Clinical Microbiology|December 1, 1989
Temafloxacin disk potency and tentative interpretive criteria for susceptibility testsA L Barry, R N Jones
Pageof 42